Royce & Associates’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.73M Buy
396,961
+48,630
+14% +$1.15M 0.1% 335
2025
Q4
$8.64M Buy
348,331
+88,978
+34% +$2.36M 0.09% 350
2025
Q3
$7.35M Sell
259,353
-48,135
-16% -$1.3M 0.07% 386
2025
Q2
$7.65M Buy
307,488
+16,781
+6% +$473K 0.08% 366
2025
Q1
$9.01M Buy
290,707
+35,155
+14% +$1.17M 0.1% 310
2024
Q4
$8.06M Buy
255,552
+140,584
+122% +$6.68M 0.07% 380
2024
Q3
$6.66M Buy
114,968
+100,000
+668% +$4.91M 0.06% 420
2024
Q2
$607K Hold
14,968
0.01% 775
2024
Q1
$629K Buy
+14,968
New +$584K 0.01% 770
2019
Q2
Sell
-22,859
Closed -$419K 1199
2019
Q1
$419K Sell
22,859
-42,125
-65% -$808K ﹤0.01% 933
2018
Q4
$1.29M Sell
64,984
-21,000
-24% -$393K 0.01% 822
2018
Q3
$1.9M Buy
+85,984
New +$1.81M 0.01% 838
2018
Q2
Sell
-208
Closed -$3K 1261
2018
Q1
$3K Buy
+208
New +$4.31K ﹤0.01% 1251

Other funds holding ASTH